Both in Lab Analytical Instruments
EyePoint vs Harvard Bioscience
Over the past year EYPT returned −96.9% and HBIO returned +111.3%; their daily moves had a correlation of -0.01.
EYPT −96.9% HBIO +111.3%Growth of $1, one year, split-adjusted
| Metric | EYPT | HBIO |
|---|---|---|
| Price | $0.3837 | $8.45 |
| Market cap | $33.1M | $38.5M |
| Today | +5.64% | +1.20% |
| 1 month | −88.8% | +6.2% |
| 6 months | −97.0% | +37.8% |
| Year to date | −97.9% | +26.3% |
| 1 year | −96.8% | +110.2% |
| Revenue growth (YoY) | −90.5% | +11.1% |
| Gross margin | 100.0% | 55.6% |
| Net margin | −18633.1% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 11.9× | 0.4× |
| Net cash | $180.5M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 454.7% | 36.2% |
| Short % of float | 25.5% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).